$ICL

Why Did ICL Group (ICL) Move Today?

Simply Wall St says ICL Group (NYSE:ICL) reported Q2 2026 sales of $2,135 million and net income of $137 million, and its board approved a new end-market operating model. The stock rose 9.90% over 30 days to $5.55 but is down 13.55% over 90 days. The article cites P/E 23.5x and a DCF value of $8.65.

Original reporting
Published Aug 16, 2026, 10:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 16, 2026, 10:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Did ICL Group (ICL) Move Today? — source image
Decision brief

The 30-second read

$ICLNeutralLow
01

Why it matters

For traders, the actionable element is the combination of reported earnings numbers and the operating-model approval, which can change expectations for segment focus and margins. However, the piece is largely valuation framing and does not provide new guidance or a quantified implementation timeline.

02

Market read

ICL is presented as rebounding on earnings clarity and operating-model change, but with persistent longer-term underperformance and cyclicality risk.

03

What to watch

The article does not quantify the operating-model’s expected cost savings or revenue uplift, so traders may be underpricing execution risk and timing uncertainty.

Relevance 4/10Novelty 4/10Timing: after-hours/late-day read-through of 2Q results and operating-model approval

Background

Simply Wall St discusses ICL’s 2Q 2026 results and a board-approved shift to a new end-market operating model, then compares valuation metrics to peers and the broader chemicals industry.

Company-level read

Ticker impact

$ICLNeutralMedium confidence
Context

ICL reported 2Q 2026 sales of $2,135M and net income of $137M, plus board approval for a new end-market operating model.

Expected impact

Near-term upside bias possible if investors buy into the operating-model execution, but follow-through depends on whether benefits materialize.

Evidence & confidence

The text provides concrete earnings figures and the board-approved operating-model shift, but it is still an interpretive valuation piece without new guidance or quantified benefit timeline.

Market effects

Signals ongoing investor focus on execution and operating-model clarity within diversified chemicals and specialty minerals.

No specific regional demand or policy linkage is provided in the article.

No explicit global macro or trade/regulatory catalyst is cited beyond general cyclicality risk.

Counterpoint

The valuation discussion (P/E vs peers and a DCF gap) may overstate opportunity if the operating-model benefits take longer to show up in earnings.

Key entities

  • ICL Group

    Reported 2Q 2026 sales of $2,135M and net income of $137M, and received board approval for a new end-market operating model.

Related articles

$ICLMed

ICL Group Q2 Earnings Call Highlights

ICL Group (NYSE:ICL) reported Q2 potash sales of $468 million (+22%) and EBITDA of $154 million (+34%). Potash price averaged $376/ton CIF (+13% YoY). Phosphate Solutions sales rose to $722 million (+13%). Management kept 2026 consolidated EBITDA guidance at $1.5B to $1.7B and reiterated sulfur and Brazil risks.

$ICLMed

ICL reports Q2 2026 sales higher by 17% to $2.1 billion

ICL reported Q2 2026 sales of $2.1 billion, up 17% from $1.8 billion a year earlier, citing stronger pricing and demand. Operating income rose to $266 million from $181 million, and net income to $137 million from $93 million. Adjusted EBITDA was $448 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion and potash volumes of 4.5 to 4.7 million metric tons.

$ICLMedAI 8/10

ICL (ICL) Q2 2026 Earnings Call Transcript

ICL Group reported Q2 2026 sales of $2.1 billion, up 17%, and adjusted EBITDA of $448 million, up 28%, citing higher potash, bromine and phosphate prices. Adjusted net income rose 35% to $149 million, and adjusted EPS rose 33% to $0.12. Free cash flow was $94 million. Full-year 2026 EBITDA guidance was reiterated at $1.5 billion to $1.7 billion.

$ICLMedAI 8/10

ICL Group LTD: ICL Reports Second Quarter 2026 Results

ICL Group (NYSE: ICL) reported Q2 2026 results for the quarter ended June 30, 2026. Consolidated sales rose to $2.1 billion (+17% Y/Y). Operating income increased to $266 million from $181 million, and net income attributable to shareholders rose to $137 million from $93 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5B to $1.7B and expects potash volumes of 4.5 to 4.7 million metric tons.

$MAIRMedAI 8/10

Billionaire Tycoon Ernesto Bertarelli Buys $219 Million in Madison Air Solutions Shares. What Does This Mean for Investors?

Billionaire Ernesto Bertarelli indirectly purchased 8.8 million shares of Madison Air Solutions (MAIR) at $24.97 per share, totaling $219 million. The acquisition was made through K.C. Armada, LP, bringing his indirect ownership to 11% of the company. MAIR's stock closed at $28.51, a 14% premium over the purchase price. The company has a market cap of $14.3 billion and expects 18% revenue growth this fiscal year.